Reardon Andrew
Reporting owner on Forms 3, 4 and 5, CIK 1950232.
Reardon Andrew reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| LGND · LIGAND PHARMACEUTICALS INCCIK 886163 | officer (CLO & Secretary) | 1 | 2026-10-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | M exercised | +340 | $52.27 | 36,854 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | S sold | -833 | $302.5107 | 36,021 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | S sold | -1,976 | $303.5444 | 34,045 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | S sold | -1,535 | $304.5154 | 32,510 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | S sold | -404 | $306.1834 | 32,106 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | S sold | -235 | $307.1911 | 31,871 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-02 | S sold | -17 | $307.74 | 31,854 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCEmployee Stock Option (right to buy), derivative | 2026-10-02 | M exercised | -340 | $0 | 29,104 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001950232-26-000003 | LIGAND PHARMACEUTICALS INC | 2026-10-06 |